Intellia Therapeutics (NTLA) EBT Margin (QoQ) (2015 - 2026)
Intellia Therapeutics (NTLA) EBT Margin (QoQ) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Intellia Therapeutics |
1.86 Bn |
1.86 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-23,276.00 |
| Dec 31, 2025 |
35,942.00 |
| Sep 30, 2025 |
-3,993.00 |
| Jun 30, 2025 |
-4,538.00 |
| Mar 31, 2025 |
30,246.00 |
| Dec 31, 2024 |
47,862.00 |
| Sep 30, 2024 |
36,414.00 |
| Jun 30, 2024 |
-146,971.00 |
| Mar 31, 2024 |
-699,786.00 |
| Dec 31, 2023 |
763,457.00 |
| Sep 30, 2023 |
-10,665.00 |
| Jun 30, 2023 |
-8,730.00 |
| Mar 31, 2023 |
-2,147.00 |
| Dec 31, 2022 |
920.00 |
| Sep 30, 2022 |
-8,519.00 |
| Jun 30, 2022 |
58,152.00 |
| Mar 31, 2022 |
-65,547.00 |
| Dec 31, 2021 |
2.33 Mn |
| Sep 30, 2021 |
-2.28 Mn |
| Jun 30, 2021 |
-33,356.00 |
